On the one hand, Guo et al. found that METTL7A expression was downregulated by data analysis in lung cancer, suggesting that METTL7A is associated with the development and progression of lung adenocarcinoma and is a potential candidate target for early diagnosis and treatment of lung adenocarcinoma [19]. The gene discussed is TMT1A; the disease is lung adenocarcinoma.